Waleed serves as Mubadala’s Deputy Group Chief Executive Officer, and has strategic oversight of the company’s broad investment portfolio and special projects at the group level. He is also a member of the investment committee, which is mandated to develop Mubadala’s investment policies, establish investment guidelines, and review proposed projects and investments to ensure they are in line with business objectives.
Waleed is also the Chairman to Mubadala's new investment and business planning committee, which approves deals within a certain financial threshold in addition to the responsibility of annual and multi-year business planning. Furthermore, Waleed has oversight of the Real Estate & Infrastructure, and Disruptive business platforms.
Prior to joining Mubadala, Waleed worked with the UAE Offsets Program Bureau as a Senior Project Manager. Past roles also include working with McKinsey & Company as a consultant.
Waleed holds a Master’s Degree in Public Policy from Harvard University, USA, and a Bachelor of Science Degree in Foreign Service from Georgetown University, USA.
Board Positions: Chairman of Waha Capital, Mubadala Capital, Global Institute for Disease Elimination (GLIDE), and the US-UAE Business Council. In addition, Waleed is a member of the Board of Trustees of Cleveland Clinic in the United States. He is also a board member of Aldar, First Abu Dhabi Bank (FAB), Hub71, Ellipses Pharma Limited, Abu Dhabi Investment Council and Investcorp.
